Skip to main content

Table 3 Timing and measures

From: Evaluating parents’ decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol

Measure

Citation

Scale information

Time 1 (pre-decision baseline, phase 1)

Time 2 (post-decision, phase 1 or 2a)

Time 2A (post-additional information decision,bphase 2)

Time 3 (short-term follow-up)

Time 4 (long-term follow-up)

Sociodemographic variables

  

X

    

Health literacy

[32]

1 item

Likert scale

X

    

Personal and family history of genetic testing

 

5 items

Yes/no

X

    

Knowledge of genomic sequencing

[38]

19 items

True/ false

X

X

 

X

 

Understanding NC NEXUS

 

5 items

True/false

X

    

General depression and anxiety

[43]

14 items

Likert scales

X

  

X

X

Decisional conflict

[44]

16 items

Likert scale

 

X

X

  

Decision regret

[45]

5 items

Likert scale

   

X

X

Decision regret for additional informationc

Adapted from [45]

6 items

Likert scale

   

X

X

Dyadic decision-making conflict

 

9 items

Likert scale

   

X

X

Test-related distress

[46]

17 items

Likert scale

   

X

X

  1. aThe time 2 questionnaire is administered in phase 1 for participants who decline NGS-NBS in the decision aid and in phase 2 for those who indicate interest in NGS-NBS in the decision aid by selecting accept or undecided
  2. bThis questionnaire is completed by decision arm participants after they decide to learn all, some, or none of the three categories of additional information
  3. c Relevant to decision arm participants only